Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Purpose: Nanocarrier-mediated ocular drug delivery offers a lot of prospects owing to its better penetration, longer retention, and bioavailability of drugs. Moreover, combination therapy provides several advantages in the treatment of ocular diseases that leads to secondary infections.